Home / News / India News / Article /
Pfizer withdraws emergency use request for its COVID-19 vaccine in India
Updated On: 06 February, 2021 08:49 AM IST | New Delhi | PTI
Pfizer was the first pharmaceutical firm to seek an emergency use authorisation from the DCGI for its COVID-19 vaccine in the country, after it secured such clearance in the UK and Bahrain
Vials with COVID-19 Vaccine stickers attached and syringes with the logo of US pharmaceutical company Pfizer. Pic/AFP
Pharma major Pfizer on Friday said it has decided to withdraw its application for Emergency Use Authorisation (EUA) of its COVID-19 vaccine in India.
Pfizer was the first pharmaceutical firm to seek an emergency use authorisation from the Drugs Controller General of India (DCGI) for its COVID-19 vaccine in the country, after it secured such clearance in the UK and Bahrain.
How do you like the new new mid-day.com experience? Share your feedback and help us improve.
Trending Stories
Latest Photos
Latest Videos
Latest Web Stories
ADVERTISEMENT
Mid-Day Fast
ADVERTISEMENT
ADVERTISEMENT